Latest AI and machine learning research in ovarian cancer for healthcare professionals.
BACKGROUND: The study aimed at developing and validating a deep learning (DL) model based on the ultrasound imaging for predicting the platinum resistance of patients with epithelial ovarian cancer (EOC).
Unsupervised learning of disease subtypes from multi-omics data presents a significant opportunity for advancing personalized medicine. We introduce OmicsCL, a modular contrastive learning framework that jointly embeds heterogeneous omics modalities-such as gene expression, DNA methylation, and miRNA expression-into a unified latent space. Our method incorporates a survival-aware contrastive los...
Molecular subtyping of breast cancer is crucial for personalized treatment and prognosis. Traditional classification approaches rely on either histo...
Motivation: Biomedical studies increasingly produce multi-view high-dimensional datasets (e.g., multi-omics) that demand integrative analysis. Exist...
This study explores a data-driven approach to discovering novel clinical and genetic markers in ovarian cancer (OC). Two main analyses were performe...
Survival prediction is a crucial task in the medical field and is essential for optimizing treatment options and resource allocation. However, curre...
Cancer of unknown primary (CUP) remains a major diagnostic hurdle, compromising therapies that depend on accurately identifying tissue of origin. We p...
The metabolic heterogeneity of breast cancer represents a significant challenge for the identification of biomarkers and therapeutic targets. To addre...
Breast cancer (BRCA) is a leading cause of cancer-related mortality in women, characterized by marked heterogeneity in molecular subtypes, immune micr...
Accurate RNA splicing is essential for gene expression and protein function, yet the mechanisms governing splice site recognition remain incompletely ...
Accurate molecular subtyping of cancer is crucial for advancing personalized medicine. Although multiomics data contain valuable predictive informatio...
Accurate breast cancer molecular subtyping is critical for treatment decisions, yet standard methods such as immunohistochemistry and gene expression ...
Controlled exit from and re-entry into the cell cycle is essential for multi-cellular life, while aberrant quiescent and senescent cell states have be...
The tumor–stroma ratio (TSR) is an established prognostic biomarker across several cancer types, yet its manual assessment remains labour-intensive an...
Homologous recombination deficiency (HRD) confers sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors and platinum-based chemotherapy, repre...
MOTIVATION: Contextual integration of multiomic datasets from the same patient could improve the accuracy of subtype prediction algorithms to help wit...
OBJECTIVE: This study aimed to develop an effective model that identifies high-risk breast cancer (BRCA) patients and optimizes clinical treatments.
Breast cancer (BRCA) is one of the most common malignancies and a leading cause of cancer-related mortality among women globally. Despite advances in ...
This paper presents a Patherea, a framework for point-based cell detection and classification that provides a complete solution for developing and e...
Accurate survival prediction is essential for personalized cancer treatment. However, genomic data - often a more powerful predictor than pathology ...